Publication:
Etiologic profile and endoscopic findings in immunocompromised children and adolescents with gastrointestinal bleeding

dc.contributor.authorChaowapong Jarasvaraparnen_US
dc.contributor.authorPornthep Tanpowpongen_US
dc.contributor.authorChatmanee Lertudomphonwaniten_US
dc.contributor.authorSuporn Treepongkarunaen_US
dc.contributor.otherUniversity of South Alabamaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-12-11T03:19:04Z
dc.date.accessioned2019-03-14T08:01:57Z
dc.date.available2018-12-11T03:19:04Z
dc.date.available2019-03-14T08:01:57Z
dc.date.issued2016-11-01en_US
dc.description.abstract© 2016 Wolters Kluwer Health, Inc. Background Gastrointestinal bleeding (GIB) is one of the potential causes of increased morbidity and mortality in immunocompromised patients, but data on characteristics of GIB in immunocompromised children are sparse. Objectives This study aimed to identify the etiology, endoscopic, and histologic findings of GIB in immunocompromised children. Design This was a retrospective descriptive study. Patients We identified 33 patients (aged<20 years) and 45 GIB episodes related to GIB between January 2007 and April 2015 from a tertiary care and teaching hospital. Results The mean age at endoscopy was 10.7±4.6 years. Most common indications for endoscopy were melena in upper GIB and hematochezia in lower GIB. The median delay of duration between GIB presentation to endoscopy was 3 days. All except one child had at least one endoscopic abnormality. The most common cause of upper GIB was cytomegalovirus (CMV)-related gastrointestinal disease (35%), followed by esophageal varices (26%), and the most common cause of lower GIB was CMV-related gastrointestinal disease (55%). Fourteen percent of patients died during upper GIB episodes and 15% died during lower GIB episodes. Conclusion Among immunocompromised individuals aged younger than 20 years presenting with GIB, CMV-related gastrointestinal disease is the most prevalent in our study population. However, the etiology of immunocompromised state needs to be taken into consideration when evaluating these children presenting with GIB.en_US
dc.identifier.citationEuropean Journal of Gastroenterology and Hepatology. Vol.28, No.11 (2016), 1293-1297en_US
dc.identifier.doi10.1097/MEG.0000000000000715en_US
dc.identifier.issn14735687en_US
dc.identifier.issn0954691Xen_US
dc.identifier.other2-s2.0-84980329536en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/41025
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84980329536&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEtiologic profile and endoscopic findings in immunocompromised children and adolescents with gastrointestinal bleedingen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84980329536&origin=inwarden_US

Files

Collections